JS
Jeffrey Ryan Stewart
EVP, Chief Commercial Officer

Jeffrey Ryan Stewart insider trades: AbbVie (ABBV) stock buys and sales

EVP, Chief Commercial Officer, AbbVie Last trade Mar 31, 2025 28 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2019
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 31, 2025ABBV↓ Sell$12.4M
Mar 18, 2024ABBV↓ Sell$10.5M
Mar 13, 2023ABBV↓ Sell$8.1M
Mar 24, 2022ABBV↓ Sell$4.4M
Mar 1, 2022ABBV↓ Sell$3.2M
Dec 15, 2021ABBV↓ Sell$275K
Mar 1, 2021ABBV↓ Sell$1.5M
Dec 29, 2020ABBV↓ Sell$2.7M
May 12, 2020ABBV↓ Sell$2.1M
Aug 16, 2019ABBV↑ Buy$1.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ABBV insiders

Open-market trades in the last 12 months

About Jeffrey Ryan Stewart's insider trades

Jeffrey Ryan Stewart is EVP, Chief Commercial Officer at AbbVie (ABBV). Since Aug 16, 2019, Jeffrey has reported 1 open-market purchase worth $1.0M and 9 sales worth $45.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (11 filings), grants and awards (9 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABBV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.